Latest News
A new BrightFocus-funded study uncovers genetic clues that could point to new strategies for regrowing neurons in people living with glaucoma.
In This Issue:
- President’s Corner
- An Artist’s Journey with Macular Degeneration: Wyncia’s Story
- Does Aspirin Increase the Risk of Permanent Vision Loss from Macular Degeneration?
- And More!
In This Issue:
- President’s Corner
- What’s Next for Alzheimer’s Treatments?
- Researcher Spotlight: Marta Casquero-Veiga, PhD
- And More!
BrightFocus Foundation has received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants over the next three years as part of its Innovative Seed Funding Program.
Boosting research investment into the health and wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years, according to a RAND report commissioned by LuMind IDSC Foundation, the Alliance for Aging Research, BrightFocus Foundation, and the National Down Syndrome Society.
Can controlling blood pressure curb mid-life Alzheimer’s risk? A BrightFocus-funded scientist investigates.
BrightFocus Foundation’s 2024 annual report highlights groundbreaking research and public awareness efforts over the last year to defeat Alzheimer’s disease, macular degeneration, and glaucoma.
Motivated by his family’s experience with eye diseases, Dr. Miguel Flores-Bellver is searching for new biomarkers of age-related macular degeneration.
A BrightFocus-funded study examines how glaucoma affects a specific retinal cell involved in mood and sleep. This research could enhance treatment development and care for the individual as vision loss advances in glaucoma.
A clinical trial for an investigational eye drop to treat wet age-related macular degeneration is seeking eligible participants for enrollment.
